QUINCE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7293 USD | +4.08% |
|
-2.76% | -30.54% |
| Jun. 26 | Transcript : Quince Therapeutics, Inc. - Special Call | |
| Jun. 25 | Quince Therapeutics Doses First Patient in Phase 3 Trial of EryDex to Treat Ataxia-Telangiectasia | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.7600 | 0.9400 | 0.9900 |
| Spread/Res. | -4.04% | -22.41% | -26.33% |
| Spread/Supp. | +12.20% | +12.20% | +4.19% |
| Support | 0.6500 | 0.6500 | 0.7000 |
- Stock Market
- Equities
- QNCX Stock
- Charts Quince Therapeutics, Inc.
